Insider Trading & Ownership of Neil Kumar

Location
Palo Alto, CA
Summary
The estimated net worth of Neil Kumar is at least $381,489,424 dollars as of 31 Mar 2026. Neil Kumar is the Chief Executive Officer, Director of BridgeBio Pharma, Inc. and owns shares of BridgeBio Pharma, Inc. (BBIO) stock worth about $373.22M. Neil Kumar is the Director of LianBio and owns shares of LianBio (LIANY) stock worth about $8.27M.
Signature
/s/ Courtney Phillips, as attorney-in-fact
All Insider Reports
All Insider Reports

Follow Filing Activity

Follow Neil Kumar and return when a new Insider Trading filing appears.

This tracks SEC filing changes for this page using existing product update flows.

Sign up to save research and follow filings

Sponsored

Quick Takeaways

  • Neil Kumar has 4 issuer positions tracked on this page.
  • Estimated disclosed ownership value: $381,489,424.
  • Recent insider filing activity is available below.

What Changed

  • Largest disclosed position: BridgeBio Pharma, Inc. ($373,218,808).
  • Past-year value change for that position: -$56,997,703.

Why This Matters

  • This page translates Forms 3/4/5 into a quick ownership context before you inspect each transaction row.
  • You can cross-check role, issuer, and filing chronology directly against the SEC source.

Official SEC Source

Filed on Form 4

Insider ownership context is sourced from SEC Forms 3, 4, and 5.

See Original Filing

Ownership of Neil Kumar

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
BBIO BridgeBio Pharma, Inc. Chief Executive Officer, Director $373,218,808 -$56,997,703 -13% 17 Mar 2026
LIANY LianBio Director $8,270,616 29 Oct 2021
BBOT BridgeBio Oncology Therapeutics, Inc. Director 11 Aug 2025
MAZE Maze Therapeutics, Inc. Director 27 Mar 2026

Insider Transactions Reported by Neil Kumar:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Sponsored